Research supports potential use of CIZ1B to help physicians assess indeterminate pulmonary nodules and guide diagnostic follow-up SAN ANTONIO, Sept. 1, 2026 /PRNewswire/ -- Cizzle Bio Inc., a biotechnology company advancing biomarker blood tests for early cancer detection, has announced...
ADVERTISEMENT
ADVERTISEMENT
2026 Copyright © News-Matic.com. All Rights Reserved
